newsfilter
← Latest News
PR Newswire·

Atrium Therapeutics to Participate in Upcoming Investor Conferences

Atrium Therapeutics, Inc. (Nasdaq: RNA), a biopharmaceutical company advancing precision cardiology by developing RNA therapeutics targeted to the...